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Abstract  
Purpose: Due to recent treatment advances, men are increasingly living longer with advanced 
prostate cancer (PCa). This study sought to understand men’s experiences of living with and 
adjusting to advanced hormone responsive PCa, and how this influenced their quality of life (QoL), in 
order to highlight how support could be optimised.  
Methods: Participants were recruited through a UK wide survey- the ‘Life After Prostate Cancer 
Diagnosis’ study. In-depth telephone interviews were conducted with 24 men (aged 46-77 years) 
with advanced (stage IV) hormone responsive PCa diagnosed 18-42 months previously. Thematic 
analysis was undertaken using a framework approach. 
Results: Most participants perceived their QoL to be relatively good, which was influenced by the 
following factors (enablers to ‘living well’ with PCa): a sense of connectedness to others, 
engagement in meaningful activities, resources (social, cognitive, financial), ability to manage 
uncertainty, utilisation of adjustment strategies and support, communication and information from 
health professionals. Barriers to ‘living well’ with PCa were often the converse of these factors. 
These also included: more troublesome PCa-related symptoms, and stronger perceptions of loss and 
restriction.  
Conclusions: In our study, men living with advanced hormone responsive PCa often reported a good 
QoL. Exploring the influences on QoL in men with advanced PCa indicates how future interventions 
might improve the QoL of men who are struggling. Further research is required to develop and test 
interventions that enhance QoL for these men.     
Introduction  
Prostate cancer (PCa) is the second most common cancer amongst men globally [1]. In the UK, 15-
26% of cases will be diagnosed with advanced PCa (stage IV) of whom 30% will survive for at least 5 
years [1,2]. Men with advanced PCa are usually offered androgen deprivation therapy (ADT), with or 
without chemotherapy, or if they are unfit, watchful waiting [3]. Recent treatment advances can 
potentially increase survival [4], so this population of men are living longer with advanced PCa. 
However, treatments such as ADT can lead to a substantial symptom burden and negatively impact 
quality of life (QoL) [5,3]. Men on ADT have a 41% increase risk of depression [6] and those with 
advanced PCa, regardless of treatment type, are also at greater risk of suicide compared to men with 
earlier stage disease [7,8]. Previous studies have focused on the challenges men face with regards to 
ADT side-effects, which can include emotional instability, lowered libido, sexual dysfunction, fatigue, 
gynecomastia, hot flushes [5,3] as well as dissatisfaction over body feminisation [9]. However, little 
previous research has focused on the strategies men adopt to manage these impacts and how men 
perceive their QoL and wellbeing.  
Our previous metasyntheses of qualitative literature illustrated men with advanced PCa can 
experience uncertainty, loss and isolation, feel physically restricted and lament altered career plans 
and a disrupted future [10-14]. However, previous qualitative research on men with advanced PCa is 
either focused specifically on symptoms [15,16,10], spirituality [17] decision making [12] or 
conducted with men ‘close to death’ [18] or with castrate-refractory PCa [19,20,10]. Few studies 
[11,21] have explored men’s coping or adjustment strategies to living with advanced PCa and 
particularly the impact of disease and treatment related challenges. Given the increasing numbers of 
men with advanced PCa living longer and in a hormone-sensitive phase, this is a significant 
information gap [4].  
The Life After Prostate Cancer Diagnosis (LAPCD) study [22], a UK population-based study aimed to 
explore the impact of PCa on men’s well-being through a survey and interviews. Given the dearth of 
studies on men living with advanced PCa, we aimed to explore the experiences of all interviewees 
living with stage IV hormone responsive PCa, drawn from the total sample of interviewed men. We 
also aimed to explore the influences on their perceived QoL and to highlight how support services 
could be optimised, as few interventions have addressed the needs of this growing population of 
men.  
Methods 
Ethics   
Ethical and regulatory approvals for the LAPCD study were obtained from Newcastle/North Tyneside 
Research Ethics Committee (15/NE/0036), Health Research Authority Confidentiality Advisory Group 
(15/CAG/0110), NHS Scotland Public Benefit and Privacy Panel (0516-0364), Northern Ireland 
Research Ethics Office (16/NI/0073). Informed consent was obtained. 
Design 
Full methodological details for the LAPCD study have been published previously [22]. Men alive 18-
42 months following PCa diagnosis (ICD10 C61) were identified through population-based cancer 
registries in England, Wales, Scotland and Northern Ireland, and mailed surveys from their treating 
Trust/Board.   Completed surveys were returned to a survey provider, Picker Institute Europe, who 
managed the data. Men in England were surveyed December 2015–March 2016, and in Scotland, 
Northern Ireland and Wales July–October 2016.  
  Respondents were asked to indicate on the survey their willingness to participate in a telephone 




Participants were selected for interview following survey completion. A purposive sampling 
framework was developed, stratified by treatment group (radical prostatectomy, external beam 
radiotherapy. brachytherapy, androgen deprivation therapy, and active surveillance / watchful 
waiting).  We also purposively included a range of men who indicated experience of either no 
problems or one or more physical (e.g. urinary incontinence, bowel problems and erectile 
dysfunction) and emotional problems (e.g. anxiety/depression), as well as men from Black, Asian and 
Minority Ethnic groups and self-identified sexualities.         
,  149 men were interviewed.  Data reported here came from a subsample (n=24, 16.1%) of this 
larger interview dataset comprising all men in the subsample with advanced hormone responsive 
stage IV PCa.  
Interviews  
Four experienced researchers (LM, JN, CR, RW) conducted semi-structured telephone interviews, 
lasting approximately one hour. Interviewers came from broad disciplinary backgrounds including 
nursing and social sciences, and included one male (RW). The LAPCD clinical and scientific advisory 
group (CSAG) and patient user advisory groups (UAGs) informed the topic guide development as did 
our previous metasyntheses [24,25,14]. The interview topic guide (online resource 1) included 
questions regarding men’s health care experiences and the psychosocial and physical impact of PCa. 
Open-ended questions and prompts were used.  
Analysis  
Interviews were transcribed verbatim, then managed using Nvivo v.11 [26]. Thematic analysis, using 
the seven stages of the framework approach [27], was employed for all men interviewed for the 
LAPCD study.. The first stage involved familiarisation, whereby researchers became immersed in the 
data and aware of key ideas and recurrent themes. Following each interview, researchers’ 
summarised key issues discussed and shared these amongst the research team for discussion.  Five 
interview transcripts were initially independently coded (EW, RW, CR, LM and JN), and discussed at 
team meetings, with input from the patient UAG and a thematic coding framework of emerging 
themes was developed.   As the analysis emerged, following subsequent interviews, this thematic 
coding framework (online resource 2) was iteratively refined. Analysis was both inductive and 
deductive, as the coding framework was primarily informed by team discussions but also used 
themes from the topic guide.  The complete dataset was then indexed, identifying data that 
corresponded to particular themes. Double coding in Nvivo11 was conducted by three authors (CR, 
EW and RW) on 10% of interviews, with final Kappa scores of ≥80% across all themes for all 
researchers. Indexed data was then arranged in charts/matrices of themes, and key ideas and 
themes summarized in the charts/matrices with relationships between them identified.  Following 
this process, we were able to determine distinctive or noteworthy subsamples for more in depth 
analysis as presented here for the sub-sample of men with hormone-responsive advanced prostate 
cancer.Analysis of the subsample involved collation of all coding frames of all men with advanced 
PCa. Men with advanced hormone responsive PCa were included but those with castrate resistant  
PCa were removed from the subsample as there were only two men in this sub-sample and their 
experiences were likely to be different. Sub sample analysis involved exploration of within-group 
convergence and divergence. Themes were further developed from the data, and discussed at team 
meetings, with input from two patient UAG members and our CSAG members. Data saturation was 
achieved. Framework matrices enabled checks to see where the subsample differed from the main 
sample of men with earlier stage (I-III) PCa. 
Findings 
Sample characteristics are presented (see Table 1). All were currently receiving ADT. Nine (37.5%) 
reported they were currently on clinical trials. The overarching concept from the interview data was 
‘enablers and barriers to living well with advanced hormone responsive PCa’.  
Enablers and Barriers to living well with advanced hormone responsive PCa 
Most men perceived they had a relatively good QoL and felt they were able to ‘live well’ with PCa, 
influenced by a number of factors. Barriers to living well with PCa were often the converse of these 
factors and also included: more troublesome PCa or comorbidity-related symptoms, and stronger 
perceptions of loss and restriction. Across the sample there appeared to be a continuum in terms of 
men’s perceived QoL, with a few men perceiving they had a poor QoL (see Figure 1). 
 
[FIGURE 1: at back] 
 
Connectedness to others  
Feeling emotionally closer to others, particularly to partners, family and friends, and having a greater 
appreciation of relationships helped give men’s lives meaning, which may have enhanced QoL. 
Despite loss of libido and sexual functioning, some men reported that over time they felt their 
spousal relationship had been strengthened. 
I have absolutely no sexual urges at all.  But it’s been really interesting how my relationship 
with my wife has actually grown up as a result.  ….we are in a good place; things have 
changed, but in fact we’ve almost realised we don’t really need it [sex] (56 years, married)  
Conversely, a few men described areas where their connectedness to others felt threatened, which 
appeared to impact on QoL. A few reported struggling with feeling inadequate as a sexual partner, 
feeling a burden on their spouses, or the loss of a sense of connection to peers (‘ [friend] basically 
told me to go away, he didn’t want to discuss it [PCa]’ 67 years, married). 
You feel inadequate.  I mean [wife’s] 58, and I love her very much.  Every day I apologise and 
say I’m sorry for what we’re going through.  And she said is it your fault?  I said I don’t know. 
(67 years, married)  
Engagement in meaningful activities   
Activities such as walking, gardening or seeing grandchildren, were perceived as influencing a good 
QoL, and also brought meaning to their lives. Some described being just as active, or even more so, 
in these pastimes than they had been before PCa, and talked about trying to make the most of the 
present as a result of their diagnosis and prognosis. A few even felt they were ‘enjoying life more’ 
following PCa. 
I’m still almost as active as I’ve always been.  I still do DIY, some gardening, play golf.  I’m 
hoping to be so for some years to come. (64 years, married) 
However, participation in activities was more limited for some following PCa diagnosis (‘I can’t really 
do exercise because I’m just tired now’ 56 years, married). Those who reported a greater symptom 
burden from PCa treatment and/or comorbidities experienced a greater sense of restriction in their 
ability to participate in valued activities. For a few, pain and fatigue meant struggling with staying 
active and being engaged in day-to-day life. Sometimes this led to forced early retirement, which 
contributed to feelings of loss over their pre-PCa lives. 
Is this life that I’m living, is this a full life?  It doesn’t feel it to me, it feels about half. (60 
years, married) 
Adjustment strategies  
Various coping strategies to adjust were described. Adjustments such as limiting the 
duration/intensity of activities enabled some to continue with normal activities, including work, 
despite fatigue and reduced stamina. Adjusting to urinary or bowel incontinence involved planning 
ahead by gaining familiarity with local toilets, and making adjustments to diet or alcohol intake.  
I need to get out; I can’t be stuck in the house all day doing nothing.  So I’ve got a little dog 
here, I take him for walks when I’m up to it.  I go out for a meal, usually a place I know, so I 
know where the toilets are. (46 years, married) 
While a few men described ongoing struggles to adjust to the changes to their sexual and masculine 
identities and relationships following sexual dysfunction, many men (with partners) reported 
strategies of reappraisal of the importance of sexual activity (‘small price to pay for still being alive’, 
72 years, married), gradual acceptance (‘as time has gone on, it doesn't bother me as much now’ 68 
years, married) and attempts at maintaining intimacy. Similarly, while a few men held ongoing 
concerns surrounding dissatisfaction over body feminisation changes brought about by ADT, such as 
reduced testicle size, breast enlargement or diminished muscle mass, others described developing 
flexibility in their beliefs regarding masculinity, and reframed changes positively. 
You have to re-evaluate yourself as a man.  But that doesn’t mean to say you can’t be a 
man… it’s amazing how switching off your testosterone supply can make you feel better 
about life!  I feel softer… perhaps more in touch with my feminine side (56 years, married) 
To manage the emotional impact, men discussed strategies of acceptance, keeping busy, positive 
thinking, making social comparisons to others worse off, using humour and, for some, taking 
antidepressant medication. Men generally preferred informal conversations with peers or spouses, 
rather than support groups. However, a few men maintained a stoical and silent approach to 
managing their emotional distress or physical problems, and struggled to raise these issues with 
health professionals.  
Having resources to help self-manage  
Men’s resources appeared to impact on their QoL, particularly social, cognitive or financial 
resources. Men often reported the benefits of spousal, family and peer support at helping them 
manage PCa. 
“I feel healthy enough in myself, we’ve got a good circle of friends, I feel really well 
supported” (71 years, married) 
Men with family living a distance away could struggle, as could those who reported little social 
support. Those with lower financial resources struggled to afford holidays, leisure activities or even 
simple hobbies, while others could afford and enjoy such activities, which they felt impacted 
positively on QoL. In terms of cognitive resources, most reported feeling confident and motivated to 
manage PCa.  
I feel I’m on top of things myself. It hasn’t become a problem; it hasn’t become restrictive so 
life goes on as much as it can as normal. (57 years, married) 
However, a few struggled with motivation to stay active and have a healthy diet, particularly if 
symptoms such as fatigue were problematic.  
Managing uncertainties  
Following the shock of diagnosis, some felt they were becoming better at tolerating and managing 
PCa-related uncertainties over time, and appeared hopeful and optimistic about the future. This was 
influenced by a determination to enjoy life, and an emphasis on the need for making short-term 
rather than long-term goals. 
I'm obviously not confident of a lengthy life but I'm quietly confident I have a few years left. 
The sell by date they've given me I've passed so every day now is a bonus (77 years, In a 
relationship) 
However, others struggled with uncertainties surrounding the future. In particular men could 
struggle with uncertainty surrounding PSA testing and some did not trust PSA testing as a reliable 
indicator of recurrence. A few were not given information on future treatments, which contributed 
to a sense of loss of control over the future.  
Support, communication and information from health care professionals  
Many participants felt their supportive care was excellent, and those on a clinical trial appreciated 
the extra support they received. 
‘Being on that trial has meant I’ve just had fantastic care’ (56 years, married) 
However, a few wanted more psychological support and reassurance, particularly more frequent 
follow-up calls. Some wished health professionals were more proactive at asking about sensitive 
issues, such as sexual dysfunction. 
I think would feel so great if you got one call, even once a month, to say how are you?  Any 
new symptoms?  Or how do you feel? (67 years, married) 
Men’s QoL appeared to be positively impacted by receiving information and effective 
communication at diagnosis and at follow-up, particularly on what to expect regarding symptoms 
and potential life expectancy. Having realistic expectations regarding prognosis helped men prepare 
themselves and motivated them to make the most of life.  
[Consultant’s] extremely good, he tells you the truth.  If you ask him a question you will get a 
straight answer (71 years, married)  
Some felt however, that they were not given enough information regarding their PSA result. A few 
participants described confusion and uncertainty over their care or treatment regimen. In particular, 
one participant had encountered unclear language regarding his prognosis at diagnosis, and had 
associated the word ‘terminal’ with meaning he had only a few months to live.  
When they first diagnosed me, I thought six months, gone.  Because that’s what you hear 
about cancer.  That’s another thing that needs to be explained, that you’re not going to die in 
six months, as far as we are aware (67 years, married) 
Discussion  
While some previous literature has highlighted that men with advanced PCa have poorer QoL 
outcomes [28,29], and are at increased risk of distress [30,31], our analysis focuses on the strategies 
that men with advanced hormone responsive PCa employ to adjust and ‘live well’. Across the 
sample, we identified a continuum in terms of men’s perceived QoL (Figure 1) with most men 
perceiving their QoL to be good. Our findings increase understanding of the key enablers and 
barriers to living well with advanced hormone responsive PCa. This is important in light of the 
increasing numbers of men with advanced PCa who are living longer with their diagnosis and in a 
hormone-sensitive treatment phase. Some of the themes we identified have previously been shown 
in men with advanced PCa, including the importance of connectedness to others [17,11,14], and a 
sense of purpose [11]. Our findings highlight how being able to engage in meaningful activities was 
particularly important for men’s QoL, even if this was unstructured simple activities such as walking. 
Similar to our findings, it has previously been shown a lower income and greater symptom burden 
are associated with poorer QoL in men with PCa [32,33].  
Our qualitative findings help explain our population-based LAPCD survey findings [34], which 
indicated while men with advanced PCa report more treatment-related problems, such as with 
hormonal functioning, overall QoL was not markedly different to men with earlier stage PCa [33,34]. 
Many themes presented were not markedly different from those for men with localised disease in 
our total sample of interviewed men. However, men with advanced PCa more often had ADT 
symptoms to manage. This was also echoed in our metasynthesis [14]. It would appear that many 
men with advanced PCa in our sample seemed to demonstrate resilience. An existing resilience 
theory - sense of coherence (SOC) theory [35], can help interpret our findings, as SOC theory explains 
how some people can maintain wellbeing despite adversity. Distress in cancer patients has been 
shown to be associated with a low SOC [36]. Three main components comprise a SOC;  a sense of 
meaningfulness, manageability and comprehensibility, impacted by a person’s resources (e.g. self-
efficacy, social support, financial resources) [35,37]. Our themes resonate with components of this 
theory, particularly the concepts of sense of meaningfulness and manageability, and the role of 
resources. Having a sense of comprehensibility was also important, as our findings indicate that 
participants could struggle if they were uncertain or confused about future treatments or PSA 
results. 
Having a sense of uncertainty has also previously been a prominent theme [14]. However, our 
findings show men’s ability to manage uncertainty over time, and the level of information and 
communication provided by health professionals regarding prognosis and treatment seemed to have 
a positive influence on QoL. An individual’s appraisal of uncertainty may also be important at 
influencing whether men view illness as a threat or an opportunity [38]. As shown previously, men 
who adopt healthier lifestyles or reconnected with others sometimes reported life was better than 
before PCa diagnosis[14].  While many previous studies in our metasynthesis [14] highlighted the 
difficulties that men face with regards to sexual dysfunction; our findings focus on the strategies that 
men adopt to overcome them. Most men appeared to have adjusted to sexual dysfunction and 
accepted that this aspect of their lives had changed. This may be reflective of the advanced 
prognosis of our sample, as the majority of previous studies have focused on men with earlier stage 
disease.  
Implications  
Health professionals could encourage men to start or continue participating in meaningful activities 
even if in a more limited way than before, and promote and identify resources to support self-
management. Activity-based interventions, such as walking or interest groups, warrant further 
investigation, as research shows the benefits of keeping active and engaged [39]. Social prescribing, 
of social, community or non-medical activities by general practitioners, may be a cost-effective way 
of getting men involved and improving QoL, however further studies in this patient group are 
warranted[40]. Future studies could also examine whether eHealth interventions might be effective 
for men who struggle to attend groups due to a high symptom burden. Meaning-focused coping 
interventions, shown to help patients manage uncertainty regarding the future, might also be worth 
exploration for men with advanced PCa [41]. 
Findings highlight the value of clear information from the clinician, in terms of prognosis, the 
implications of PSA test results, and treatment planning.  It is important that health professionals 
take care in the language they use and avoid using the word ‘terminal’ for men with advanced PCa 
with a reasonable prognosis. This is important as misperceptions of medical terminology has been 
shown in the general population, of whom most are not able to distinguish between the terms 
‘terminal’ or ‘advanced’ [42]. It might be useful for men to be made aware at diagnosis that many 
men living with advanced PCa are able to live for many years and experience a good QoL. However, 
it is important for health professionals to assess how much information men want regarding their 
prognosis, as not all men may wish to know this. Future research could further investigate how 
prognosis is discussed during appointments.  
It is also important that health professionals consider the impact of men’s constructions of 
hegemonic masculinity and how this may impact on their approach to help-seeking for physical or 
psychological problems, as a few men struggled to raise these issues, also shown previously [43]. 
Screening tools may be useful to identify men who are reluctant to discuss their concerns, such as 
the Patient Concerns Inventory. Health professionals could use such instruments as a discussion tool 
during appointments. 
Limitations 
Men in our sample were 18-42 months post diagnosis and were on ADT. A third were part of a 
clinical trial, which may mean they had a more positive experience of healthcare, and a 
disproportionate number were younger (<65 years). Our findings therefore provide a snapshot of 
the experiences of men who are relatively close to diagnosis with hormone-responsive PCa, and may 
not be reflective of the experiences of all men with stage IV disease.  As the majority of men treated 
with ADT will progress to metastatic castrate-resistant PCa, associated with a greater symptom 
burden [44,45], men from this group require further study.    
Conclusions 
Findings indicate key dimensions that seemed to influence QoL and men’s ability to ‘live well’ with 
advanced hormone responsive PCa.  This may also have relevance for patients living with other types 
of advanced cancer. Further research is required to develop and test interventions for men with a 
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Table 1. Participant characteristics  
Variable Total N=24 
Age  Mean Range 
 66.29 46-77 
Age group N % 
<55 1 4.2 
55-64 years 8 33.3 
65-74 years 13 54.1 
75-84 years 2 8.3 
Nation   
England 10 41.6 
Wales 4 16.6 
Northern Ireland 3 12.5 
Scotland 7 29.1 
Marital status   
Married/civil partnership 20 83.3 
In a relationship 2 8.3 
Divorced or widowed 1 4.1 
Single 1 4.1 
Sexual Orientation    
Heterosexual 22 91.6 
Gay or bisexual 2 8.3 
Ethnicity   
White British 23 95.8 
Black British  1 4.1 
Treatment a   
EBRT + HT 5 20.8 
HT + chemotherapy 3 12.5 
HT only 12 50.0 
EBRT + HT + chemotherapy 4 16.6 
Time since diagnosis   
24-29 months 10 41.6 
30-35 months 4 16.6 
36-42 months 10 41.6 




• Sense of connectedness to others
• Ability to engage in meaningful 
activities
• Utilisation of adjustment 
strategies
• Having resources to help self-
manage (social, cognitive,  
financial) 
• Ability to manage and tolerate 
uncertainties
• Feeling supported and informed 
by health care team
Barriers
• Threatened sense of connectedness 
• Disrupted ability to engage in 
meaningful activities 
• Difficulties utilising adjustment 
strategies
• Low resources to self-manage 
(social, cognitive, financial)
• Struggling to manage uncertainties
• Perceptions of inadequate support 
and information from health care 
team
• High symptom severity 
• Perceptions of restriction and loss
Good Quality of life continuum                         Poor
Figure 1:  The quality of life continuum: enablers and barriers to living well with hormone-
responsive advanced prostate cancer
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